Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
24-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
24-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #35190
advertisement
Honjo M
13
Showing records 1 to 13 |
Display all abstracts from
Honjo M
112865
Effects of Brimonidine, Omidenepag Isopropyl, and Ripasudil Ophthalmic Solutions to Protect against HO-Induced Oxidative Stress in Human Trabecular Meshwork Cells
Liu M
Current Eye Research
2023; 48: 1014-1025
112959
Apoptosis inhibitor of macrophages/CD5L enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension
Nemoto H
Journal of Cellular Physiology
2023; 238: 2451-2467
112247
Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Aoyama Y
Graefe's Archive for Clinical and Experimental Ophthalmology
2024; 262: 191-201
112959
Apoptosis inhibitor of macrophages/CD5L enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension
Honjo M
Journal of Cellular Physiology
2023; 238: 2451-2467
112247
Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Sakata R
Graefe's Archive for Clinical and Experimental Ophthalmology
2024; 262: 191-201
112865
Effects of Brimonidine, Omidenepag Isopropyl, and Ripasudil Ophthalmic Solutions to Protect against HO-Induced Oxidative Stress in Human Trabecular Meshwork Cells
Honjo M; Yamagishi R
Current Eye Research
2023; 48: 1014-1025
112247
Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Fujishiro T
Graefe's Archive for Clinical and Experimental Ophthalmology
2024; 262: 191-201
112959
Apoptosis inhibitor of macrophages/CD5L enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension
Arai S; Miyazaki T
Journal of Cellular Physiology
2023; 238: 2451-2467
112247
Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Honjo M
Graefe's Archive for Clinical and Experimental Ophthalmology
2024; 262: 191-201
112865
Effects of Brimonidine, Omidenepag Isopropyl, and Ripasudil Ophthalmic Solutions to Protect against HO-Induced Oxidative Stress in Human Trabecular Meshwork Cells
Aihara M
Current Eye Research
2023; 48: 1014-1025
112247
Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Shirato S
Graefe's Archive for Clinical and Experimental Ophthalmology
2024; 262: 191-201
112959
Apoptosis inhibitor of macrophages/CD5L enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension
Aihara M
Journal of Cellular Physiology
2023; 238: 2451-2467
112247
Contributing factors for intraocular pressure control in patients with mostly normal-tension glaucoma after initial Ex-PRESS drainage device implantation
Aihara M
Graefe's Archive for Clinical and Experimental Ophthalmology
2024; 262: 191-201
Issue
24-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept